Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin K1 route comparison for excessive warfarin anticoagulation after mechanical valve replacement
ChiCTR2000029013Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of phytomenadione and warfarin in Cardiac valve disease (VHD) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: INR, warfarin-related gene polymorphism and 2 more. Started Jan 2020; status: recruiting.
02
Drugs
phytomenadionewarfarin
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on ChiCTR2000029013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029013.